JP2014512812A5 - - Google Patents

Info

Publication number

JP2014512812A5

JP2014512812A5 JP2014502699A JP2014502699A JP2014512812A5 JP 2014512812 A5 JP2014512812 A5 JP 2014512812A5 JP 2014502699 A JP2014502699 A JP 2014502699A JP 2014502699 A JP2014502699 A JP 2014502699A JP 2014512812 A5 JP2014512812 A5 JP 2014512812A5

Authority

JP

Japan

Prior art keywords

seq

nos

antibody

amino acid

cdr1

Prior art date

2012-04-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 41
• 230000027455 binding Effects 0.000 claims description 35
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
• 239000000427 antigen Substances 0.000 claims description 21
• 102000036639 antigens Human genes 0.000 claims description 21
• 108091007433 antigens Proteins 0.000 claims description 21
• 108010088729 HLA-A*02:01 antigen Proteins 0.000 claims description 18
• 239000012634 fragment Substances 0.000 claims description 14
• 108010074032 HLA-A2 Antigen Proteins 0.000 claims description 8
• 102000025850 HLA-A2 Antigen Human genes 0.000 claims description 8
• 108010081208 RMFPNAPYL Proteins 0.000 claims description 7
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
• 206010027406 Mesothelioma Diseases 0.000 claims description 4
• 239000003814 drug Substances 0.000 claims description 4
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 3
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
• 229940079593 drug Drugs 0.000 claims description 2
• 239000003053 toxin Substances 0.000 claims description 2
• 231100000765 toxin Toxicity 0.000 claims description 2
• 108020004707 nucleic acids Proteins 0.000 claims 14
• 102000039446 nucleic acids Human genes 0.000 claims 14
• 150000007523 nucleic acids Chemical class 0.000 claims 14
• 239000008194 pharmaceutical composition Substances 0.000 claims 13
• 201000010099 disease Diseases 0.000 claims 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 7
• 238000000034 method Methods 0.000 claims 5
• 239000002773 nucleotide Substances 0.000 claims 5
• 125000003729 nucleotide group Chemical group 0.000 claims 5
• 210000001519 tissue Anatomy 0.000 claims 5
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 4
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 4
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 4
• 150000001413 amino acids Chemical class 0.000 claims 4
• 206010000830 Acute leukaemia Diseases 0.000 claims 2
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 2
• 206010006187 Breast cancer Diseases 0.000 claims 2
• 208000026310 Breast neoplasm Diseases 0.000 claims 2
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 2
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 2
• 208000034578 Multiple myelomas Diseases 0.000 claims 2
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 2
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 2
• 206010028980 Neoplasm Diseases 0.000 claims 2
• 206010033128 Ovarian cancer Diseases 0.000 claims 2
• 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
• 206010060862 Prostate cancer Diseases 0.000 claims 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
• 208000024207 chronic leukemia Diseases 0.000 claims 2
• 231100000433 cytotoxic Toxicity 0.000 claims 2
• 230000001472 cytotoxic effect Effects 0.000 claims 2
• 208000005017 glioblastoma Diseases 0.000 claims 2
• 208000025113 myeloid leukemia Diseases 0.000 claims 2
• 229940124597 therapeutic agent Drugs 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 1
• 102000004169 proteins and genes Human genes 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 210000004027 cell Anatomy 0.000 description 45
• 102100022748 Wilms tumor protein Human genes 0.000 description 15
• 102000025171 antigen binding proteins Human genes 0.000 description 5
• 108091000831 antigen binding proteins Proteins 0.000 description 5
• 108020001507 fusion proteins Proteins 0.000 description 5
• 102000037865 fusion proteins Human genes 0.000 description 5
• 208000032839 leukemia Diseases 0.000 description 4
• 108010032595 Antibody Binding Sites Proteins 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• IBNSYSWDJJQKSY-PJYANRIDSA-N C([C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 IBNSYSWDJJQKSY-PJYANRIDSA-N 0.000 description 1
• 101100189167 Capsicum chinense VAMT gene Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 101710094648 Coat protein Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 241000282838 Lama Species 0.000 description 1
• 229940110339 Long-acting muscarinic antagonist Drugs 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• MVZGYPSXNDCANY-UHFFFAOYSA-N N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-quinazolinyl]-2-propenamide Chemical compound FC1=CC=CC(COC=2C(=CC(NC=3C4=CC(NC(=O)C=C)=CC=C4N=CN=3)=CC=2)Cl)=C1 MVZGYPSXNDCANY-UHFFFAOYSA-N 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 101710083689 Probable capsid protein Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 239000002254 cytotoxic agent Substances 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 230000033581 fucosylation Effects 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960002743 glutamine Drugs 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 238000005305 interferometry Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 238000011533 pre-incubation Methods 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 238000013391 scatchard analysis Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1